Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ophthalmology

  Free Subscription


Articles published in J Ocul Pharmacol Ther

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    June 2019
  1. WRIGHT CB, Becker SM, Low LA, Tagle DA, et al
    Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.
    J Ocul Pharmacol Ther. 2019 Jun 5. doi: 10.1089/jop.2018.0139.
    PubMed     Text format     Abstract available


    May 2019
  2. RAGELLE H, Goncalves A, Kustermann S, Antonetti DA, et al
    Organ-On-A-Chip Technologies for Advanced Blood-Retinal Barrier Models.
    J Ocul Pharmacol Ther. 2019 May 29. doi: 10.1089/jop.2019.0017.
    PubMed     Text format     Abstract available


  3. LI C, Feng X, Wen X, Li Y, et al
    A Pilot Clinical Study of Intravitreal Injection of Artesunate for Ocular Neovascularization.
    J Ocul Pharmacol Ther. 2019 May 15. doi: 10.1089/jop.2018.0097.
    PubMed     Text format     Abstract available


  4. SEBBAG L, Yan Y, Smith JS, Allbaugh RA, et al
    Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.
    J Ocul Pharmacol Ther. 2019 May 9. doi: 10.1089/jop.2019.0020.
    PubMed     Text format     Abstract available


  5. PERAGINE C, Walker SAN, Walker S, Palmay L, et al
    Fluoroquinolone Antibiotic Prophylaxis to Prevent Post-Traumatic Bacterial Infectious Endophthalmitis: Using Monte Carlo Simulation to Evaluate the Probability of Success.
    J Ocul Pharmacol Ther. 2019 May 8. doi: 10.1089/jop.2019.0013.
    PubMed     Text format     Abstract available


  6. AASEN DM, Vergara MN
    New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids.
    J Ocul Pharmacol Ther. 2019 May 6. doi: 10.1089/jop.2018.0140.
    PubMed     Text format     Abstract available


    April 2019
  7. CHO YK, Shin EY, Uehara H, Ambati B, et al
    Antiangiogenesis Effect of Albendazole on the Cornea.
    J Ocul Pharmacol Ther. 2019 Apr 27. doi: 10.1089/jop.2018.0103.
    PubMed     Text format     Abstract available


  8. WOODWARD DF, Wang JW, Coleman RA, Woodrooffe AJ, et al
    A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method.
    J Ocul Pharmacol Ther. 2019 Apr 25. doi: 10.1089/jop.2018.0126.
    PubMed     Text format     Abstract available


  9. TASKAR P, Adelli G, Patil A, Lakhani P, et al
    Analog Derivatization of Cannabidiol for Improved Ocular Permeation.
    J Ocul Pharmacol Ther. 2019 Apr 18. doi: 10.1089/jop.2018.0141.
    PubMed     Text format     Abstract available


  10. YANG L, Qiu Y, Liu J, Lin R, et al
    Retinal Transcriptome Analysis in the Treatment of Endotoxin-Induced Uveitis with Tetramethylpyrazine Eye Drops.
    J Ocul Pharmacol Ther. 2019 Apr 17. doi: 10.1089/jop.2018.0105.
    PubMed     Text format     Abstract available


  11. BANTSEEV V, Miller PE, Nork TM, Rasmussen CA, et al
    Determination of a No Observable Effect Level for Endotoxin Following a Single Intravitreal Administration to Cynomolgus Monkeys.
    J Ocul Pharmacol Ther. 2019 Apr 9. doi: 10.1089/jop.2018.0149.
    PubMed     Text format     Abstract available


  12. ABDEL-MEGUID AAE, Gabr AF, Said MM, Hamid Nassef MAE, et al
    Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery.
    J Ocul Pharmacol Ther. 2019 Apr 5. doi: 10.1089/jop.2018.0088.
    PubMed     Text format     Abstract available


    March 2019
  13. BROWN GC, Brown MM
    Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2019 Mar 28. doi: 10.1089/jop.2018.0114.
    PubMed     Text format     Abstract available


  14. HAN DP, Skumatz C, Besharse JC, Kassem IS, et al
    Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency.
    J Ocul Pharmacol Ther. 2019 Mar 27. doi: 10.1089/jop.2018.0085.
    PubMed     Text format     Abstract available


  15. CAVET ME, Glogowski S, Lowe ER, Phillips E, et al
    Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38.
    J Ocul Pharmacol Ther. 2019 Mar 23. doi: 10.1089/jop.2018.0136.
    PubMed     Text format     Abstract available


  16. WOLFRAM C, Stahlberg E, Pfeiffer N
    Patient-Reported Nonadherence with Glaucoma Therapy.
    J Ocul Pharmacol Ther. 2019 Mar 21. doi: 10.1089/jop.2018.0134.
    PubMed     Text format     Abstract available


  17. WANG T, Li W, Zhong L, Ye H, et al
    Evaluation of the Effects of Biohcly in an In Vivo Model of Mechanical Wounds in the Rabbit Cornea.
    J Ocul Pharmacol Ther. 2019 Mar 19. doi: 10.1089/jop.2018.0098.
    PubMed     Text format     Abstract available


  18. ITAKURA T, Webster A, Chintala SK, Wang Y, et al
    GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure.
    J Ocul Pharmacol Ther. 2019 Mar 11. doi: 10.1089/jop.2018.0135.
    PubMed     Text format     Abstract available


    February 2019
  19. CHO HJ, Jung SH, Cho S, Han JO, et al
    Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy.
    J Ocul Pharmacol Ther. 2019 Feb 26. doi: 10.1089/jop.2018.0107.
    PubMed     Text format     Abstract available


  20. TEKIN S, Seven E, Batur M
    Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2019 Feb 13. doi: 10.1089/jop.2018.0124.
    PubMed     Text format     Abstract available


    January 2019
  21. LEE SS, Dibas M, Almazan A, Robinson MR, et al
    Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure.
    J Ocul Pharmacol Ther. 2019 Jan 30. doi: 10.1089/jop.2018.0095.
    PubMed     Text format     Abstract available


  22. GEORGAKOPOULOS CD, Plotas P, Kagkelaris K, Tsapardoni F, et al
    Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2019 Jan 28. doi: 10.1089/jop.2018.0113.
    PubMed     Text format     Abstract available


  23. ARBABI A, Liu A, Ameri H
    Gene Therapy for Inherited Retinal Degeneration.
    J Ocul Pharmacol Ther. 2019 Jan 28. doi: 10.1089/jop.2018.0087.
    PubMed     Text format     Abstract available


  24. NELSON WW, Lima AF, Kranyak J, Opong-Owusu B, et al
    Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States.
    J Ocul Pharmacol Ther. 2019 Jan 24. doi: 10.1089/jop.2018.0090.
    PubMed     Text format     Abstract available


  25. YANG KB, Zhang H, Li SJ, Cao JJ, et al
    Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
    J Ocul Pharmacol Ther. 2019 Jan 22. doi: 10.1089/jop.2018.0093.
    PubMed     Text format     Abstract available


  26. SAMY KE, Cao Y, Kim J, Konichi da Silva NR, et al
    Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device.
    J Ocul Pharmacol Ther. 2019 Jan 7. doi: 10.1089/jop.2018.0096.
    PubMed     Text format     Abstract available


  27. GONZALEZ-DE LA ROSA A, Navarro-Partida J, Altamirano-Vallejo JC, Hernandez-Gamez AG, et al
    Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.
    J Ocul Pharmacol Ther. 2019 Jan 7. doi: 10.1089/jop.2018.0101.
    PubMed     Text format     Abstract available


  28. CHUA PY, Clare G, Leslie T
    Re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study" by Jin and Lee (J. Ocul. Pharmacol. Ther. 34:274-279, 2018).
    J Ocul Pharmacol Ther. 2019;35:3-4.
    PubMed     Text format    


  29. JIN SW
    Response to Chua et al. re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study".
    J Ocul Pharmacol Ther. 2019;35:5.
    PubMed     Text format    


  30. RODIER JT, Tripathi R, Fink MK, Sharma A, et al
    Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene Delivery.
    J Ocul Pharmacol Ther. 2019;35:23-31.
    PubMed     Text format     Abstract available



  31. Correction to: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial, by Baiza-Duran, L., Olvera-Montano, O., Mercado-Sesma, A
    J Ocul Pharmacol Ther. 2019;35:76.
    PubMed     Text format    


    December 2018
  32. ZHANG J, Zhou K, Zhang X, Zhou Y, et al
    Celastrol Ameliorates Inflammation in Human Retinal Pigment Epithelial Cells by Suppressing NF-kappaB Signaling.
    J Ocul Pharmacol Ther. 2018 Dec 31. doi: 10.1089/jop.2018.0092.
    PubMed     Text format     Abstract available


  33. YATES KA, Shanks RMQ, Kowalski RP, Romanowski EG, et al
    The In Vitro Evaluation of Povidone-Iodine Against Multiple Ocular Adenoviral Types.
    J Ocul Pharmacol Ther. 2018 Dec 27. doi: 10.1089/jop.2018.0122.
    PubMed     Text format     Abstract available


  34. WOODWARD DF, Wang JW, Ni M, Bauer AJ, et al
    In Vivo Choroidal Neovascularization and Macrophage Studies Provide Further Evidence for a Broad Role of Prostacyclin in Angiogenesis.
    J Ocul Pharmacol Ther. 2018 Dec 14. doi: 10.1089/jop.2018.0077.
    PubMed     Text format     Abstract available


    November 2018
  35. RANGARAJAN R, Ketelson H
    Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium.
    J Ocul Pharmacol Ther. 2018 Nov 29. doi: 10.1089/jop.2018.0031.
    PubMed     Text format     Abstract available


  36. CALLANAN D, Kunimoto D, Maturi RK, Patel SS, et al
    Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2018 Nov 9. doi: 10.1089/jop.2018.0062.
    PubMed     Text format     Abstract available


  37. EKANAYAKA SA, McClellan SA, Peng X, Barrett RP, et al
    HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice.
    J Ocul Pharmacol Ther. 2018 Nov 8. doi: 10.1089/jop.2018.0073.
    PubMed     Text format     Abstract available


  38. LAKHANI P, Patil A, Majumdar S
    Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.
    J Ocul Pharmacol Ther. 2018 Nov 8. doi: 10.1089/jop.2018.0089.
    PubMed     Text format     Abstract available


  39. HOUBEN I, De Zaeytijd J, Deghislage C, Frost NA, et al
    Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Occlusion-Related Macular Edema and Effect of Prior Vitrectomy.
    J Ocul Pharmacol Ther. 2018 Nov 7. doi: 10.1089/jop.2018.0012.
    PubMed     Text format     Abstract available


    October 2018
  40. CELIKER H, Kazokoglu H, Direskeneli H
    Factors Affecting Relapse and Remission in Behcet's Uveitis Treated with Interferon Alpha2a.
    J Ocul Pharmacol Ther. 2018 Oct 25. doi: 10.1089/jop.2018.0083.
    PubMed     Text format     Abstract available


  41. REE YS, Back HM, Yun HY, Ahn JH, et al
    Dose Optimization Based on Population Pharmacokinetic Modeling of High-Dose Cyclosporine, a P-glycoprotein Inhibitor, in Combination with Systemic Chemotherapy in Pediatric Patients with Retinoblastoma.
    J Ocul Pharmacol Ther. 2018 Oct 18. doi: 10.1089/jop.2018.0041.
    PubMed     Text format     Abstract available


  42. SZEGEDI S, Scheschy U, Schmidl D, Aranha Dos Santos V, et al
    Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0069.
    PubMed     Text format     Abstract available


  43. LA GATTA A, Corsuto L, Salzillo R, D'Agostino A, et al
    In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0046.
    PubMed     Text format     Abstract available


  44. MOON I, Kang HG, Yeo A, Noh H, et al
    Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0005.
    PubMed     Text format     Abstract available


  45. GOLDSTEIN AS, Aldrich BT, Skeie JM, Schmidt GA, et al
    Assessing the Effects of Ripasudil, a Novel Rho Kinase Inhibitor, on Human Corneal Endothelial Cell Health.
    J Ocul Pharmacol Ther. 2018 Oct 12. doi: 10.1089/jop.2018.0063.
    PubMed     Text format     Abstract available


  46. DAULL P, Raymond E, Feraille L, Garrigue JS, et al
    Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.
    J Ocul Pharmacol Ther. 2018 Oct 12. doi: 10.1089/jop.2018.0040.
    PubMed     Text format     Abstract available


  47. CHUN YH, Beak JU, Kim HS, Na KS, et al
    Topical Cyclosporine Pretreatment of Ocular Surface in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    J Ocul Pharmacol Ther. 2018 Oct 5. doi: 10.1089/jop.2018.0006.
    PubMed     Text format     Abstract available


    September 2018
  48. TORIYAMA K, Suzuki T, Shiraishi A
    Characteristics of Infectious Keratitis in Old and Very Old Patients.
    J Ocul Pharmacol Ther. 2018 Sep 15. doi: 10.1089/jop.2018.0028.
    PubMed     Text format     Abstract available


  49. YOON CH, Park JW, Ryu JS, Kim MK, et al
    Corneal Toxicity of Topical Tacrolimus Ointment in Mice with Corneal Epithelial Injury.
    J Ocul Pharmacol Ther. 2018 Sep 15. doi: 10.1089/jop.2018.0054.
    PubMed     Text format     Abstract available


  50. BOZIC M, Stojkovic M, Knezevic M, Marjanovic I, et al
    Is the Use of Refrigerated Fixed Combination of Dorzolamide 2%-Timolol 0.5% (COSOPT) Associated with Less Ocular Discomfort? A Pilot Study.
    J Ocul Pharmacol Ther. 2018 Sep 11. doi: 10.1089/jop.2018.0023.
    PubMed     Text format     Abstract available


  51. SEIBOLD LK, Wagner BD, Lynch AM, Kahook MY, et al
    The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy.
    J Ocul Pharmacol Ther. 2018 Sep 7. doi: 10.1089/jop.2018.0050.
    PubMed     Text format     Abstract available


  52. WILL-ORREGO A, Qiu Y, Fassbender ES, Shen S, et al
    Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
    J Ocul Pharmacol Ther. 2018;34:489-499.
    PubMed     Text format     Abstract available


    August 2018
  53. GADE SK, Shivshetty N, Sharma N, Bhatnagar S, et al
    Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
    J Ocul Pharmacol Ther. 2018 Aug 23. doi: 10.1089/jop.2018.0059.
    PubMed     Text format     Abstract available


  54. REZKALLAH A, Malcles A, Dot C, Voirin N, et al
    Evaluation of Efficacy and Safety of Dexamethasone Intravitreal Implants of Vitrectomized and Nonvitrectomized Eyes in a Real-World Study.
    J Ocul Pharmacol Ther. 2018 Aug 17. doi: 10.1089/jop.2018.0007.
    PubMed     Text format     Abstract available


  55. GARCIA-FEIJOO J, Hoh H, Uzunov R, Dickerson JE Jr, et al
    Supraciliary Microstent in Refractory Open-Angle Glaucoma: Two-Year Outcomes from the DUETTE Trial.
    J Ocul Pharmacol Ther. 2018 Aug 3. doi: 10.1089/jop.2018.0036.
    PubMed     Text format     Abstract available


    July 2018
  56. LIN YC, Horng LY, Sung HC, Wu RT, et al
    Sodium Iodate Disrupted the Mitochondrial-Lysosomal Axis in Cultured Retinal Pigment Epithelial Cells.
    J Ocul Pharmacol Ther. 2018 Jul 18. doi: 10.1089/jop.2017.0073.
    PubMed     Text format     Abstract available


  57. FRAUNFELDER FT, Fraunfelder FW
    Oral Anti-Vascular Endothelial Growth Factor Drugs and Ocular Side Effects.
    J Ocul Pharmacol Ther. 2018 Jul 13. doi: 10.1089/jop.2018.0019.
    PubMed     Text format     Abstract available


  58. FUWA M, Toris CB, Fan S, Taniguchi T, et al
    Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys.
    J Ocul Pharmacol Ther. 2018 Jul 10. doi: 10.1089/jop.2017.0146.
    PubMed     Text format     Abstract available


  59. AIHARA M
    Response to Novack re: "Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes".
    J Ocul Pharmacol Ther. 2018;34:431.
    PubMed     Text format    


    June 2018
  60. GUIMARAES DE SOUZA R, Yu Z, Stern ME, Pflugfelder SC, et al
    Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.
    J Ocul Pharmacol Ther. 2018 Jun 29. doi: 10.1089/jop.2018.0047.
    PubMed     Text format     Abstract available


  61. NOVACK GD
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jun 20. doi: 10.1089/jop.2018.0048.
    PubMed     Text format    


    May 2018
  62. KAKIMOTO H, Takamura Y, Arimura S, Miyake S, et al
    Effect of 0.05% Difluprednate Ophthalmic Emulsion on Proinflammatory Cytokine Levels After Retinal Laser Photocoagulation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 29. doi: 10.1089/jop.2017.0109.
    PubMed     Text format     Abstract available


  63. ZHAO X, Tong Y, Wang X, Zhang X, et al
    Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 24. doi: 10.1089/jop.2017.0139.
    PubMed     Text format     Abstract available


  64. CHAKRAVARTI T
    The Association of Socioeconomic Status with Severity of Glaucoma and the Impacts of Both Factors on the Costs of Glaucoma Medications: A Cross-Sectional Study in West Bengal, India.
    J Ocul Pharmacol Ther. 2018 May 15. doi: 10.1089/jop.2017.0135.
    PubMed     Text format     Abstract available


  65. CHO YK, Shin EY, Uehara H, Ambati B, et al
    The Effect of 0.5% Timolol Maleate on Corneal(Lymph)Angiogenesis in a Murine Suture Model.
    J Ocul Pharmacol Ther. 2018 May 14. doi: 10.1089/jop.2017.0119.
    PubMed     Text format     Abstract available


  66. TRAN HDM, Tran YH, Tran TD, Jong M, et al
    A Review of Myopia Control with Atropine.
    J Ocul Pharmacol Ther. 2018 May 1. doi: 10.1089/jop.2017.0144.
    PubMed     Text format     Abstract available


    April 2018
  67. SMITH A, Pawar M, Van Dort ME, Galban S, et al
    Ocular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0126.
    PubMed     Text format     Abstract available


  68. GARAY-ARAMBURU G, Gomez-Moreno A
    A 5-Year Follow-Up Study of the Treatment of Macular Edema Due to Retinal Vein Occlusion Using Dexamethasone Intravitreal Implants.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0148.
    PubMed     Text format     Abstract available


  69. BAIZA-DURAN L, Olvera-Montano O, Mercado-Sesma AR, Oregon-Miranda AA, et al
    Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2018;34:250-255.
    PubMed     Text format     Abstract available


    March 2018
  70. RUANGVARAVATE N, Prabhasawat P, Vachirasakchai V, Tantimala R, et al
    High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand.
    J Ocul Pharmacol Ther. 2018 Mar 29. doi: 10.1089/jop.2017.0104.
    PubMed     Text format     Abstract available


  71. ZHU S, Xu X, Liu K, Gu Q, et al
    PAPep Inhibits Secretion of Poly(I:C)-Induced Inflammatory Cytokines and ICAM-1 Expression in Corneal Fibroblasts by Suppressing the NF-kappaB/p38 Pathway.
    J Ocul Pharmacol Ther. 2018 Mar 27. doi: 10.1089/jop.2017.0068.
    PubMed     Text format     Abstract available


    February 2018
  72. NOVACK GD, Moyer ED
    Slit Lamp-Based Ocular Scoring Systems: Commentary.
    J Ocul Pharmacol Ther. 2018 Feb 26. doi: 10.1089/jop.2018.29039.
    PubMed     Text format    


  73. KAZEMI A, McLaren JW, Kopczynski CC, Heah TG, et al
    The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.
    J Ocul Pharmacol Ther. 2018 Feb 22. doi: 10.1089/jop.2017.0138.
    PubMed     Text format     Abstract available


  74. OZGONUL C, Dedania VS, Besirli CG
    Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0074.
    PubMed     Text format     Abstract available


  75. UCAN GUNDUZ G, Parmak Yener N, Kilincel O, Gunduz C, et al
    How Does Usage of Serotonin Noradrenaline Reuptake Inhibitors Affect Intraocular Pressure in Depression Patients?
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0133.
    PubMed     Text format     Abstract available


  76. PAPANGKORN K, Higuchi JW, Brar B, Higuchi WI, et al
    Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
    J Ocul Pharmacol Ther. 2018 Feb 12. doi: 10.1089/jop.2017.0093.
    PubMed     Text format     Abstract available


  77. BACHU RD, Stepanski M, Alzhrani RM, Jung R, et al
    Development and Evaluation of a Novel Microemulsion of Dexamethasone and Tobramycin for Topical Ocular Administration.
    J Ocul Pharmacol Ther. 2018 Feb 6. doi: 10.1089/jop.2017.0082.
    PubMed     Text format     Abstract available


  78. CARLSON E, Kao WWY, Ogundele A
    Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model.
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0080.
    PubMed     Text format     Abstract available



  79. Correction to: The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma, by Katsanos, A., Dastiridou, A.I., Quaranta, L., Rulli, E., Riva, I., Dimasi, V., Tsir
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0030.
    PubMed     Text format    


  80. DINC E, Ayaz L, Kurt AH
    Effects of Bevacizumab, Ranibizumab, and Aflibercept on MicroRNA Expression in a Retinal Pigment Epithelium Cell Culture Model of Oxidative Stress.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0128.
    PubMed     Text format     Abstract available


  81. YAZICI A, Sari E, Ayhan E, Sahin G, et al
    The Effect of Low-Dose Aspirin on Dry Eye Parameters and Ocular Surface Disease Index Questionnaire.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0064.
    PubMed     Text format     Abstract available


    January 2018
  82. KARACA ADIYEKE S, Ture G, Talay E
    Intravitreal Dexamethasone Implant for Postvitrectomy Macular Edema: A Retrospective Cohort of 14 Patients (Postvitrectomy Macular Edema Treatment).
    J Ocul Pharmacol Ther. 2018 Jan 29. doi: 10.1089/jop.2017.0107.
    PubMed     Text format     Abstract available


  83. NJIE-MBYE YF, Robinson J, Mitchell-Bush L, Mckoy M, et al
    Pharmacology of Serotonin Receptors Causing Contraction of Isolated Bovine Posterior Ciliary Arteries: Role in Ocular Blood Flow.
    J Ocul Pharmacol Ther. 2018 Jan 25. doi: 10.1089/jop.2017.0124.
    PubMed     Text format     Abstract available


  84. OHIA SE, Njie-Mbye YF, Robinson J, Mitchell L, et al
    Serotonin-2B/2C Receptors Mediate Bovine Ciliary Muscle Contraction: Role in Intraocular Pressure Regulation.
    J Ocul Pharmacol Ther. 2018 Jan 24. doi: 10.1089/jop.2017.0123.
    PubMed     Text format     Abstract available


  85. SINGH S, Agarwal R, Abdul Razak Z, Ngu R, et al
    Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
    J Ocul Pharmacol Ther. 2018 Jan 17. doi: 10.1089/jop.2017.0098.
    PubMed     Text format     Abstract available


  86. SHARIF NA
    iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0125.
    PubMed     Text format     Abstract available


  87. SEKINE Y, Shimada M, Satake S, Okubo M, et al
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0091.
    PubMed     Text format     Abstract available


  88. JIN SW, Lee SM
    The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
    J Ocul Pharmacol Ther. 2018 Jan 3. doi: 10.1089/jop.2017.0075.
    PubMed     Text format     Abstract available


    December 2017
  89. CHUNG JK, Spencer E, Hunt M, McCauley T, et al
    Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
    J Ocul Pharmacol Ther. 2017 Dec 21. doi: 10.1089/jop.2017.0106.
    PubMed     Text format     Abstract available


  90. EKANAYAKA SA, McClellan SA, Barrett RP, Hazlett LD, et al
    Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
    J Ocul Pharmacol Ther. 2017 Dec 13. doi: 10.1089/jop.2017.0094.
    PubMed     Text format     Abstract available


  91. WATERBURY LD
    Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model.
    J Ocul Pharmacol Ther. 2017 Dec 11. doi: 10.1089/jop.2017.0048.
    PubMed     Text format     Abstract available


  92. OHIA SE, Robinson J, Mitchell L, Ngele KK, et al
    Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.
    J Ocul Pharmacol Ther. 2017 Dec 7. doi: 10.1089/jop.2017.0077.
    PubMed     Text format     Abstract available


  93. SCHMITT HM, Schlamp CL, Nickells RW
    Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0059.
    PubMed     Text format     Abstract available


  94. KHAN S, Warade S, Singhavi DJ
    Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0079.
    PubMed     Text format     Abstract available


  95. HARTMAN RR, Kompella UB
    Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.
    J Ocul Pharmacol Ther. 2017 Dec 5. doi: 10.1089/jop.2017.0121.
    PubMed     Text format     Abstract available


  96. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology.
    J Ocul Pharmacol Ther. 2017;33:718-734.
    PubMed     Text format     Abstract available


    November 2017
  97. MASUOKA T, Gallar J, Belmonte C
    Inhibitory Effect of Amitriptyline on the Impulse Activity of Cold Thermoreceptor Terminals of Intact and Tear-Deficient Guinea Pig Corneas.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0066.
    PubMed     Text format     Abstract available


  98. CHEN Y, Hua R
    Therapeutic Efficacy of Conbercept for Inflammatory Choroidal Neovascularization.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0097.
    PubMed     Text format    


  99. BANTSEEV V, Erickson R, Leipold D, Amaya C, et al
    Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0063.
    PubMed     Text format     Abstract available


  100. MIOTTO S, Zemella N, Gusson E, Panozzo G, et al
    Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0022.
    PubMed     Text format     Abstract available


  101. SUWANNOI P, Chomnawang M, Sarisuta N, Reichl S, et al
    Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0057.
    PubMed     Text format     Abstract available


  102. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    Slit Lamp-Based Ocular Scoring Systems in Toxicology and Drug Development: A Literature Survey.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0021.
    PubMed     Text format     Abstract available


  103. DI ZAZZO A, Roberti G, Mashaghi A, Abud TB, et al
    Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications.
    J Ocul Pharmacol Ther. 2017;33:670-677.
    PubMed     Text format     Abstract available


    October 2017
  104. PAPANGKORN K, Prendergast E, Higuchi JW, Brar B, et al
    Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
    J Ocul Pharmacol Ther. 2017 Oct 12. doi: 10.1089/jop.2017.0053.
    PubMed     Text format     Abstract available


  105. MOUSTAFA MT, Ramirez C, Schneider K, Atilano SR, et al
    Protective Effects of Memantine on Hydroquinone-Treated Human Retinal Pigment Epithelium Cells and Human Retinal Muller Cells.
    J Ocul Pharmacol Ther. 2017;33:610-619.
    PubMed     Text format     Abstract available


    September 2017
  106. GARWEG JG, Niderprim SA, Russ HM, Pfister IB, et al
    Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Sep 27. doi: 10.1089/jop.2017.0006.
    PubMed     Text format     Abstract available


  107. LIN CJ, Chen HS, Su CW, Tien PT, et al
    The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    J Ocul Pharmacol Ther. 2017 Sep 26. doi: 10.1089/jop.2017.0070.
    PubMed     Text format     Abstract available


  108. CORCORAN P, Hollander DA, Ousler GW 3rd, Angjeli E, et al
    Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


  109. GUERRA M, Marques S, Quadrado Gil J, Campos J, et al
    Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


    July 2017
  110. PENG SY, Lai CC, Wang NK, Wu WC, et al
    Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:466-472.
    PubMed     Text format     Abstract available


    June 2017
  111. BARANOV P, Lin H, McCabe K, Gale D, et al
    A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue.
    J Ocul Pharmacol Ther. 2017;33:412-422.
    PubMed     Text format     Abstract available


  112. ROLANDO M, Vagge A
    Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:383-390.
    PubMed     Text format     Abstract available


  113. SANCHEZ-AVILA RM, Merayo-Lloves J, Riestra AC, Anitua E, et al
    The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:391-399.
    PubMed     Text format     Abstract available


    May 2017
  114. TERADA Y, Kamoi K, Komizo T, Miyata K, et al
    Human T Cell Leukemia Virus Type 1 and Eye Diseases.
    J Ocul Pharmacol Ther. 2017;33:216-223.
    PubMed     Text format     Abstract available


  115. WEI JR, Wen X, Bible PW, Li Z, et al
    Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.
    J Ocul Pharmacol Ther. 2017;33:285-289.
    PubMed     Text format     Abstract available


    April 2017
  116. RUBSAM A, Thieme CE, Schlomberg J, Winterhalter S, et al
    Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:141-148.
    PubMed     Text format     Abstract available


  117. SELEN F, Tekeli O, Yanik O
    Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs.
    J Ocul Pharmacol Ther. 2017;33:170-175.
    PubMed     Text format     Abstract available


    March 2017
  118. BAO X, Hou M, Qin Y, Luo F, et al
    Effect of an MG132-Sustained Drug Delivery Capsular Ring on the Inhibition of Posterior Capsule Opacification in a Rabbit Model.
    J Ocul Pharmacol Ther. 2017;33:103-110.
    PubMed     Text format     Abstract available


  119. TORKILDSEN G, Abelson MB, Gomes PJ, McLaurin E, et al
    Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
    J Ocul Pharmacol Ther. 2017;33:79-90.
    PubMed     Text format     Abstract available


  120. PARK Y, Song JS, Choi CY, Yoon KC, et al
    A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
    J Ocul Pharmacol Ther. 2017;33:66-72.
    PubMed     Text format     Abstract available


    January 2017
  121. PFLUGFELDER SC, Stern M, Zhang S, Shojaei A, et al
    LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2017;33:5-12.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: